HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.

Abstract
Deregulation of the ubiquitin/proteasome system has been implicated in the pathogenesis of many human diseases, including cancer. Ubiquitin-specific proteases (USP) are cysteine proteases involved in the deubiquitination of protein substrates. Functional connections between USP7 and essential viral proteins and oncogenic pathways, such as the p53/Mdm2 and phosphatidylinositol 3-kinase/protein kinase B networks, strongly suggest that the targeting of USP7 with small-molecule inhibitors may be useful for the treatment of cancers and viral diseases. Using high-throughput screening, we have discovered HBX 41,108, a small-molecule compound that inhibits USP7 deubiquitinating activity with an IC(50) in the submicromolar range. Kinetics data indicate an uncompetitive reversible inhibition mechanism. HBX 41,108 was shown to affect USP7-mediated p53 deubiquitination in vitro and in cells. As RNA interference-mediated USP7 silencing in cancer cells, HBX 41,108 treatment stabilized p53, activated the transcription of a p53 target gene without inducing genotoxic stress, and inhibited cancer cell growth. Finally, HBX 41,108 induced p53-dependent apoptosis as shown in p53 wild-type and null isogenic cancer cell lines. We thus report the identification of the first lead-like inhibitor against USP7, providing a structural basis for the development of new anticancer drugs.
AuthorsFrédéric Colland, Etienne Formstecher, Xavier Jacq, Céline Reverdy, Cécile Planquette, Susan Conrath, Virginie Trouplin, Julie Bianchi, Vasily N Aushev, Jacques Camonis, Alessandra Calabrese, Catherine Borg-Capra, Wolfgang Sippl, Vincent Collura, Guillaume Boissy, Jean-Christophe Rain, Philippe Guedat, Rémi Delansorne, Laurent Daviet
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 8 Issue 8 Pg. 2286-95 (Aug 2009) ISSN: 1538-8514 [Electronic] United States
PMID19671755 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HBX 41,108
  • Indenes
  • Protease Inhibitors
  • Pyrazines
  • Tumor Suppressor Protein p53
  • USP7 protein, human
  • Ubiquitin Thiolesterase
  • Ubiquitin-Specific Peptidase 7
Topics
  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Humans
  • Indenes (pharmacology)
  • Protease Inhibitors (pharmacology)
  • Pyrazines (pharmacology)
  • Tumor Suppressor Protein p53 (genetics, metabolism)
  • Ubiquitin Thiolesterase (antagonists & inhibitors, metabolism)
  • Ubiquitin-Specific Peptidase 7

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: